Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Orlynvah (sulopenem etzadroxil and probenecid) for the Treatment of Uncomplicated Urinary Tract Infections
Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), today announced that the U.S. Food and Drug Administration (FDA) has approved Iterum’s new drug...
ED Visit Rate 36.1 per 1,000 Older Adults With Alzheimer Disease
For adults aged 65 years and older with Alzheimer disease, the emergency department visit rate was 36.1 visits per 1,000 adults in 2020 to 2022, according...
Female Pediatricians Earn About 93 Percent of Male Pediatricians
Female pediatricians earn about 93 percent of what male pediatricians earn, according to a study published online Oct. 29 in Pediatrics.Mary Pat Frintner,...
Healthy Eating Index 2015 Score Linked to Overactive Bladder
There is a positive association between a higher Healthy Eating Index (HEI)-2015 score and overactive bladder (OAB), according to a study published online...
Many Seniors at Risk for Financial Precarity From Cost of Hospital Stay
Many Medicare beneficiaries are at risk for financial hardship from the costs of a single hospital stay, according to a study published online Oct. 29...
Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
SAN FRANCISCO, Oct. 29, 2024. Nektar Therapeutics today announced the publication of peer-reviewed data from two Phase 1b studies in Nature Communications...
Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug...
How AI Might Help Men Fighting Prostate Cancer
Artificial intelligence might be able to help doctors detect the prostate cancers most likely to be life-threatening to men, a new study suggests. An...
Iowa Resident Dies of Suspected Lassa Fever After Trip to West Africa
Health officials are investigating the case of an Iowa resident who died of Lassa fever after traveling recently to West Africa. The Ebola-like virus...
AI Might Help Pick Up Heart Trouble in Dogs
Artificial intelligence can accurately detect heart murmurs in dogs, a new study finds. The AI program detects heart murmurs in canines with 90% accuracy,...
Childhood Attention Issues Show Links to Later Risk for Psychosis, Schizophrenia
Most kids with attention issues won't go on to develop serious psychiatric conditions like psychosis or schizophrenia. However, a new study finds poor...
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with Keytruda (pembrolizumab) After Neoadjuvant Keytruda and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
(BUSINESS WIRE) October 28, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (Nasdaq: MRNA), today...
Over 50? How Long You Can Stand on One Leg Is Important
There's a simple test available to seniors who want to quickly check how well they’re aging: see how long you can stand on one leg. Folks over 50...
Recently Added
Recently added consumer and prescribing information: Imuldosa, Hympavzi, Flyrcado, Otulfi, Tecentriq Hybreza, Pavblu, Livdelzi, Yorvipath, Crexont, Lymphir
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Orlynvah Orlynvah (sulopenem etzadroxil and probenecid) is a penem antibacterial and renal tubular transport inhibitor combination used for the...
- Vyloy Vyloy (zolbetuximab-clzb) is a claudin 18.2-directed cytolytic antibody used for the combination treatment of patients with HER2-negative...
- Vyalev Vyalev (foscarbidopa and foslevodopa) is a carbidopa prodrug and levodopa prodrug combination indicated for the treatment of motor...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...